Subbu Nambi
Stock Analyst at Guggenheim
(4.87)
# 323
Out of 4,509 analysts
166
Total ratings
70.2%
Success rate
34.8%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintained: Buy | $50 → $70 | $58.97 | +18.70% | 9 | Jun 29, 2026 | |
| ILMN Illumina | Maintained: Buy | $180 → $200 | $190.05 | +5.24% | 12 | Jun 29, 2026 | |
| VCYT Veracyte | Maintained: Buy | $45 → $65 | $57.48 | +13.08% | 10 | Jun 29, 2026 | |
| NTRA Natera | Maintained: Buy | $270 → $290 | $272.89 | +6.27% | 7 | Jun 29, 2026 | |
| GH Guardant Health | Maintained: Buy | $135 → $160 | $158.40 | +1.01% | 15 | Jun 29, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $60 → $107 | $90.35 | +18.43% | 9 | Jun 29, 2026 | |
| ADPT Adaptive Biotechnologies | Maintained: Buy | $21 → $22 | $21.02 | +4.66% | 4 | Jun 29, 2026 | |
| WGS GeneDx Holdings | Maintained: Buy | $70 → $74 | $63.85 | +15.90% | 8 | Jun 29, 2026 | |
| BLLN BillionToOne | Maintained: Buy | $120 → $125 | $123.25 | +1.42% | 6 | Jun 29, 2026 | |
| TEM Tempus AI | Maintained: Buy | $60 | $55.93 | +7.28% | 9 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $71.80 | +4.46% | 11 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $373.22 | +17.89% | 5 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.36 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $15.04 | -13.56% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $22.98 | +104.53% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.72 | +22.38% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $15.71 | -23.62% | 4 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.78 | +124.72% | 8 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.65 | +24.35% | 7 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 → $235 | $200.16 | +17.41% | 7 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $144.88 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.49 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.11 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $111.11 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | $249.50 | +5.41% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $17.06 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.86 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $41.77 | n/a | 2 | Feb 23, 2025 |
Bruker
Jun 29, 2026
Maintained: Buy
Price Target: $50 → $70
Current: $58.97
Upside: +18.70%
Illumina
Jun 29, 2026
Maintained: Buy
Price Target: $180 → $200
Current: $190.05
Upside: +5.24%
Veracyte
Jun 29, 2026
Maintained: Buy
Price Target: $45 → $65
Current: $57.48
Upside: +13.08%
Natera
Jun 29, 2026
Maintained: Buy
Price Target: $270 → $290
Current: $272.89
Upside: +6.27%
Guardant Health
Jun 29, 2026
Maintained: Buy
Price Target: $135 → $160
Current: $158.40
Upside: +1.01%
Twist Bioscience
Jun 29, 2026
Maintained: Buy
Price Target: $60 → $107
Current: $90.35
Upside: +18.43%
Adaptive Biotechnologies
Jun 29, 2026
Maintained: Buy
Price Target: $21 → $22
Current: $21.02
Upside: +4.66%
GeneDx Holdings
Jun 29, 2026
Maintained: Buy
Price Target: $70 → $74
Current: $63.85
Upside: +15.90%
BillionToOne
Jun 29, 2026
Maintained: Buy
Price Target: $120 → $125
Current: $123.25
Upside: +1.42%
Tempus AI
Jun 1, 2026
Maintained: Buy
Price Target: $60
Current: $55.93
Upside: +7.28%
May 26, 2026
Reiterated: Buy
Price Target: $75
Current: $71.80
Upside: +4.46%
May 11, 2026
Reiterated: Buy
Price Target: $440
Current: $373.22
Upside: +17.89%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $6.36
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $13
Current: $15.04
Upside: -13.56%
May 7, 2026
Maintained: Buy
Price Target: $47
Current: $22.98
Upside: +104.53%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $5.72
Upside: +22.38%
May 5, 2026
Maintained: Buy
Price Target: $10 → $12
Current: $15.71
Upside: -23.62%
Apr 28, 2026
Reiterated: Buy
Price Target: $4
Current: $1.78
Upside: +124.72%
Apr 27, 2026
Maintained: Buy
Price Target: $12
Current: $9.65
Upside: +24.35%
Apr 21, 2026
Reiterated: Buy
Price Target: $275 → $235
Current: $200.16
Upside: +17.41%
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $144.88
Upside: -
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.49
Upside: -
Oct 28, 2025
Maintained: Hold
Price Target: n/a
Current: $14.11
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $111.11
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: $249.50
Upside: +5.41%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $17.06
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $5.86
Upside: n/a
Feb 23, 2025
Maintained: Hold
Price Target: n/a
Current: $41.77
Upside: n/a